Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$120,358,727
-$9,375,919 QoQ
Shares Held
981,879
-20.2% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#17
of 341 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. PTGX ranks #15 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in PTGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,358,727 | 981,879 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $129,734,646 | 1,230,879 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $117,946,119 | 1,350,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $68,431,801 | 1,030,134 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $59,384,740 | 1,074,448 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $52,773,865 | 1,091,271 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $49,086,153 | 1,271,662 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,855,335 | 1,374,563 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,961,667 | 1,268,735 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $28,765,764 | 994,323 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $8,788,151 | 383,260 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $17,585,273 | 1,054,273 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $40,594,798 | 1,469,761 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $22,198,496 | 965,152 | Shares | Sole | 2023-05-16 | |
| 2020-12-31 | $4,104,394 | 203,591 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||